PUK30 Once Monthly Erythropoiesis Stimulating Agent (ESA) Dosing May Reduce ESA Utilization Compared to Thrice-Weekly ESA Dosing
Jun 1, 2012, 00:00 AM
10.1016/j.jval.2012.03.850
https://www.valueinhealthjournal.com/article/S1098-3015(12)00915-1/fulltext
Section Title :
Urinary/Kidney Disorders
Section Order :
337
First Page :
A158
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00915-1&doi=10.1016/j.jval.2012.03.850